The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksNNN.L Regulatory News (NNN)

  • There is currently no data for NNN

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Disposal of Cloudveil and Board Change

1 Nov 2021 07:00

RNS Number : 7984Q
Nanosynth Group PLC
01 November 2021
 

1 November 2021

The information contained within this announcement is deemed by the Company to constitute inside information as stipulated under the Market Abuse Regulations (EU) No. 596/2014 ('MAR') which has been incorporated into UK law by the European Union (Withdrawal) Act 2018. Upon the publication of this announcement via a Regulatory Information Service ('RIS'), this inside information is now considered to be in the public domain.

 

nanosynth group plc

("nanosynth", the "Company" or the "Group")

Disposal of Cloudveil and Board Change

The Board of nanosynth announces that it has agreed to return control of Cloudveil Limited ("Cloudveil"), a wholly owned subsidiary of the Company, to Cloudveil's founder, Antony Hugo Gillum-Webb (the "Founder"), by transferring the Company's shares in Cloudveil to the Founder for nominal consideration (the "Disposal"), effective immediately.

The Disposal is in line with the Board's strategy which is to focus on the synthesis and application of the Company's core capabilities and has been strengthened by the appointment of Mark Duffin as CEO in September 2021. The Disposal follows the Board's decision earlier this year to reduce its holding in Gyrometric Systems Limited, as approved by shareholders in August 2021, and following this the Group will have two wholly owned subsidiaries, being Pharm 2 Farm Ltd ("P2F") and nanosynth Ltd.

The Board also announces that following the Gyrometric transaction, John Richardson has resigned from the Board as an executive director, effective immediately, to focus on product management activities within P2F, the Company's main subsidiary.

Antony Hugo Gillum-Webb is also a director of Cloudveil and as a result, the Disposal is considered to be a related party transaction in accordance with Rule 13 of the AIM Rules for Companies. Accordingly, the Directors of nanosynth, being Mark Duffin, Antony Legge, Richard Clarke, Dr Felicity Sartain and Dr Gareth Cave, having consulted with the Company's nominated adviser, SP Angel Corporate Finance LLP, consider that the terms of the Disposal are fair and reasonable insofar as the Company's shareholders are concerned.

Antony Legge, Chairman of nanosynth, said: "The disposals of Gyrometric and Cloudveil are the last steps in our refocussing strategy. With the opportunities available to us, it is vital our management and financial resources are concentrated on realising returns for shareholders by exploiting our strong position within the nano-particle sector."

- ENDS -

Enquiries:

Nanosynth group plc

+44 77 6355 5919

Mark Duffin (CEO)

SP Angel Corporate Finance LLP 

+44 20 3470 0470

Stuart Gledhill

Caroline Rowe

IFC Advisory Ltd 

+44 20 3934 6630 

Graham Herring

Tim Metcalfe

Zach Cohen

Information on Cloudveil

Cloudveil was founded in November 2017 as an intelligence services and security risk management business. Nanosynth acquired a 100% interest in Cloudveil on 26 September 2019 for a consideration of £130,000 which was settled by the issue of nanosynth shares. Goodwill arising on the acquisition was fully impaired in the group accounts during the year ended 31 December 2019. In the year ended 31 December 2020 Cloudveil's revenues were £20,118 and it made a loss before tax of £109,359. Cloudveil's net liabilities at 31 December 2020 were £119,046. Since 31 December 2020 Cloudveil has continued to accrue losses with turnover for the 6 months to 30 June 2021 being £2,000 and the loss before tax of £31,775. At 31 December 2020 nanosynth had provided funding of £114,000 to Cloudveil which had been fully provided in the individual accounts of nanosynth at that date. Further funding has been made by nanosynth in the subsequent period of £115,000.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DISZZMZGVLKGMZM
Date   Source Headline
17th Nov 20237:00 amRNSCancellation - Nanosynth Group PLC
14th Nov 20234:10 pmRNSCompany Insolvency
29th Sep 20237:00 amRNSAccounts Update
30th Aug 20233:30 pmRNSAppointment of Joint Broker
30th Aug 20237:00 amRNSResignation of Finance Director
28th Jul 20233:53 pmRNSResignation of Chief Executive Officer
26th Jun 202311:24 amRNSAccounts Update
14th Jun 20233:27 pmRNSNotice re. General Meeting
24th May 20232:27 pmRNSNotice of General Meeting
16th May 202312:28 pmRNSProposal to Appoint Liquidators
16th May 202312:03 pmRNSSuspension - Nanosynth Group plc
28th Apr 20237:00 amRNSHolding(s) in Company
6th Apr 20233:05 pmRNSFinancial Position
31st Jan 20237:00 amRNSTotal Voting Rights
26th Jan 20233:42 pmRNSDirectorate Change
20th Jan 202310:48 amRNSHolding(s) in Company
17th Jan 20237:00 amRNSCorporate and Commercial Update
10th Jan 20237:00 amRNSPlacing and Subscription to raise £0.4 million
4th Jan 20232:56 pmRNSHolding(s) in Company
30th Sep 20227:00 amRNSHalf-year Report
6th Sep 20224:47 pmRNSHolding(s) in Company
1st Sep 20227:00 amRNSTotal Voting Rights
31st Aug 20224:41 pmRNSSecond Price Monitoring Extn
31st Aug 20224:35 pmRNSPrice Monitoring Extension
31st Aug 20222:05 pmRNSSecond Price Monitoring Extn
31st Aug 20222:00 pmRNSPrice Monitoring Extension
31st Aug 202211:05 amRNSSecond Price Monitoring Extn
31st Aug 202211:00 amRNSPrice Monitoring Extension
31st Aug 20229:05 amRNSSecond Price Monitoring Extn
31st Aug 20229:00 amRNSPrice Monitoring Extension
31st Aug 20227:00 amRNSSuccessful Trial Results
30th Aug 20227:00 amRNSJoint Development Agreement in Cosmetics Market
26th Aug 20227:00 amRNSLanstead Subscription and Sharing Agreement
1st Aug 20222:05 pmRNSSecond Price Monitoring Extn
1st Aug 20222:00 pmRNSPrice Monitoring Extension
1st Aug 20221:08 pmRNSPDMR Dealings
26th Jul 20222:41 pmRNSResult of AGM
12th Jul 202211:06 amRNSSecond Price Monitoring Extn
12th Jul 202211:00 amRNSPrice Monitoring Extension
12th Jul 20229:05 amRNSSecond Price Monitoring Extn
12th Jul 20229:00 amRNSPrice Monitoring Extension
11th Jul 20224:40 pmRNSSecond Price Monitoring Extn
11th Jul 20224:36 pmRNSPrice Monitoring Extension
11th Jul 20222:06 pmRNSSecond Price Monitoring Extn
11th Jul 20222:00 pmRNSPrice Monitoring Extension
11th Jul 202211:05 amRNSSecond Price Monitoring Extn
11th Jul 202211:00 amRNSPrice Monitoring Extension
11th Jul 202210:30 amRNSDirector/PDMR dealings
6th Jul 20229:00 amRNSPrice Monitoring Extension
5th Jul 20222:05 pmRNSSecond Price Monitoring Extn

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.